Original article
Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: 2 Turkish hospital experience
Sunitinib versus pazopanib para el tratamiento del carcinoma de células renales metastásico: experiencia en 2 hospitales turcos
Read
521
Timeswas read the article
20
Total PDF
501
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 10 | 25 | 0 | 25 |
| 2025 9 | 43 | 12 | 55 |
| 2025 8 | 15 | 0 | 15 |
| 2025 7 | 23 | 2 | 25 |
| 2025 6 | 17 | 3 | 20 |
| 2025 5 | 14 | 0 | 14 |
| 2025 4 | 12 | 0 | 12 |
| 2025 3 | 18 | 0 | 18 |
| 2025 2 | 18 | 0 | 18 |
| 2025 1 | 53 | 0 | 53 |
| 2024 12 | 15 | 0 | 15 |
| 2024 11 | 13 | 0 | 13 |
| 2024 10 | 8 | 0 | 8 |
| 2024 9 | 18 | 0 | 18 |
| 2024 8 | 34 | 0 | 34 |
| 2024 7 | 6 | 1 | 7 |
| 2024 6 | 13 | 0 | 13 |
| 2024 5 | 11 | 0 | 11 |
| 2024 4 | 12 | 0 | 12 |
| 2024 3 | 7 | 0 | 7 |
| 2024 2 | 10 | 0 | 10 |
| 2024 1 | 12 | 0 | 12 |
| 2023 12 | 7 | 0 | 7 |
| 2023 11 | 10 | 0 | 10 |
| 2023 10 | 13 | 1 | 14 |
| 2023 9 | 9 | 0 | 9 |
| 2023 8 | 8 | 0 | 8 |
| 2023 7 | 4 | 0 | 4 |
| 2023 6 | 4 | 0 | 4 |
| 2023 5 | 4 | 0 | 4 |
| 2023 4 | 3 | 0 | 3 |
| 2023 3 | 4 | 0 | 4 |
| 2023 2 | 4 | 0 | 4 |
| 2023 1 | 1 | 0 | 1 |
| 2022 12 | 2 | 0 | 2 |
| 2022 11 | 2 | 0 | 2 |
| 2022 10 | 4 | 0 | 4 |
| 2022 9 | 3 | 0 | 3 |
| 2022 8 | 2 | 0 | 2 |
| 2022 7 | 3 | 0 | 3 |
| 2022 6 | 2 | 0 | 2 |
| 2022 5 | 2 | 0 | 2 |
| 2022 4 | 4 | 0 | 4 |
| 2022 3 | 3 | 0 | 3 |
| 2022 2 | 4 | 0 | 4 |
| 2022 1 | 1 | 0 | 1 |
| 2020 1 | 1 | 1 | 2 |
Show all
